BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 28549792)

  • 1. Endocannabinoids modulate apoptosis in endometriosis and adenomyosis.
    Bilgic E; Guzel E; Kose S; Aydin MC; Karaismailoglu E; Akar I; Usubutun A; Korkusuz P
    Acta Histochem; 2017 Jun; 119(5):523-532. PubMed ID: 28549792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of the CB
    Khan MI; Sobocińska AA; Brodaczewska KK; Zielniok K; Gajewska M; Kieda C; Czarnecka AM; Szczylik C
    BMC Cancer; 2018 May; 18(1):583. PubMed ID: 29792186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opposing roles of CB
    Gobira PH; Oliveira AC; Gomes JS; da Silveira VT; Asth L; Bastos JR; Batista EM; Issy AC; Okine BN; de Oliveira AC; Ribeiro FM; Del Bel EA; Aguiar DC; Finn DP; Moreira FA
    Br J Pharmacol; 2019 May; 176(10):1541-1551. PubMed ID: 30101419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoid receptor-dependent metabolism of 2-arachidonoylglycerol during aging.
    Pascual AC; Gaveglio VL; Giusto NM; Pasquaré SJ
    Exp Gerontol; 2014 Jul; 55():134-42. PubMed ID: 24768821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Cannabinoid Receptors in Myometrium and its Correlation With Dysmenorrhea in Adenomyosis.
    Shen X; Duan H; Wang S; Hong W; Wang YY; Lin SL
    Reprod Sci; 2019 Dec; 26(12):1618-1625. PubMed ID: 30832539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocannabinoids and Their Pharmacological Actions.
    Pertwee RG
    Handb Exp Pharmacol; 2015; 231():1-37. PubMed ID: 26408156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased Expression of Cannabinoid Receptors in the Eutopic and Ectopic Endometrium of Patients with Adenomyosis.
    Shen X; Duan H; Wang S; Gan L; Xu Q; Li JJ
    Biomed Res Int; 2019; 2019():5468954. PubMed ID: 30800671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opposite effects of cannabinoid CB
    Li L; Dong X; Tu C; Li X; Peng Z; Zhou Y; Zhang D; Jiang J; Burke A; Zhao Z; Jin L; Jiang Y
    Br J Pharmacol; 2019 Apr; 176(7):890-905. PubMed ID: 30707759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacology of cannabinoid receptors and their ligands: an overview.
    Pertwee RG
    Int J Obes (Lond); 2006 Apr; 30 Suppl 1():S13-8. PubMed ID: 16570099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabis, cannabinoid receptors, and endocannabinoid system: yesterday, today, and tomorrow.
    Wu J
    Acta Pharmacol Sin; 2019 Mar; 40(3):297-299. PubMed ID: 30670816
    [No Abstract]   [Full Text] [Related]  

  • 11. Elevated Systemic Levels of Endocannabinoids and Related Mediators Across the Menstrual Cycle in Women With Endometriosis.
    Sanchez AM; Cioffi R; Viganò P; Candiani M; Verde R; Piscitelli F; Di Marzo V; Garavaglia E; Panina-Bordignon P
    Reprod Sci; 2016 Aug; 23(8):1071-9. PubMed ID: 26887427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoid CB
    Olianas MC; Dedoni S; Onali P
    Life Sci; 2021 Jul; 276():119407. PubMed ID: 33794254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cannabinoid receptor CB1 contributes to the development of ectopic lesions in a mouse model of endometriosis.
    Sanchez AM; Quattrone F; Pannese M; Ulisse A; Candiani M; Diaz-Alonso J; Velasco G; Panina-Bordignon P
    Hum Reprod; 2017 Jan; 32(1):175-184. PubMed ID: 27821707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cannabinoid receptor CB1 affects the proliferation and apoptosis of adenomyotic human uterine smooth muscle cells of the junctional zone: a mechanism study.
    Wang S; Li B; Shen X; Duan H; Guo Z; Li X; Sun F
    Reprod Biol Endocrinol; 2021 Feb; 19(1):16. PubMed ID: 33531043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CB2 cannabinoid receptor agonist selectively inhibits the mechanosensitivity of mucosal afferents in the guinea pig bladder.
    Christie S; Zagorodnyuk V
    Am J Physiol Renal Physiol; 2021 May; 320(5):F859-F865. PubMed ID: 33749323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution and function of the endocannabinoid system in the rat and human bladder.
    Bakali E; Elliott RA; Taylor AH; Willets J; Konje JC; Tincello DG
    Int Urogynecol J; 2013 May; 24(5):855-63. PubMed ID: 23081739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological inhibition of CB1 cannabinoid receptor protects against doxorubicin-induced cardiotoxicity.
    Mukhopadhyay P; Bátkai S; Rajesh M; Czifra N; Harvey-White J; Haskó G; Zsengeller Z; Gerard NP; Liaudet L; Kunos G; Pacher P
    J Am Coll Cardiol; 2007 Aug; 50(6):528-36. PubMed ID: 17678736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands.
    Davis MP
    Expert Opin Investig Drugs; 2014 Aug; 23(8):1123-40. PubMed ID: 24836296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The therapeutic role of cannabinoid receptors and its agonists or antagonists in Parkinson's disease.
    Han QW; Yuan YH; Chen NH
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jan; 96():109745. PubMed ID: 31442553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Insights of Uterine Leiomyoma Pathogenesis: Endocannabinoid System.
    Ayakannu T; Taylor AH; Marczylo TH; Konje JC
    Med Sci Monit Basic Res; 2019 Mar; 25():76-87. PubMed ID: 30842391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.